Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-01-04
2011-01-04
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S008000, C536S018100
Reexamination Certificate
active
07863248
ABSTRACT:
A tyrosinase activity inhibitor and an ameliorant for facial blood flow that are excellent in terms of safety, and medicinal compositions, food compositions, and cosmetic preparations that contain the inhibitor and the ameliorant as active ingredients are provided. A tyrosinase activity inhibitor and an ameliorant for facial blood flow that contain anthocyan obtained by concentration or extraction of plant material, and medicinal compositions, food compositions, and cosmetic preparations that have an inhibitory action on tyrosinase activity and ameliorating action on facial blood flow are provided.
REFERENCES:
patent: 5670154 (1997-09-01), Hara et al.
patent: 6767999 (2004-07-01), Smirnov et al.
patent: 1208755 (2002-05-01), None
patent: 2723316 (1996-02-01), None
patent: A2-62-048611 (1987-03-01), None
patent: A-62-077328 (1987-04-01), None
patent: 11-255637 (1999-09-01), None
patent: 2002-029980 (2002-01-01), None
patent: 2002-053468 (2002-02-01), None
patent: 2002-068993 (2002-03-01), None
patent: 2002-128689 (2002-05-01), None
patent: 2003-277271 (2003-10-01), None
patent: 2004-107245 (2004-04-01), None
patent: 2004-262878 (2004-09-01), None
patent: WO 01/01798 (2001-01-01), None
patent: WO 01/52809 (2001-07-01), None
patent: WO 03/053336 (2003-07-01), None
Office Action dated Feb. 9, 2009 in corresponding Canadian patent application No. 2,543,676.
A. Colantuoni, et al. “Effects of Vaccinium Myrtillus Anthocyanosides on Arterial Vasomotion,”Arzneimittel Forschung. Drug Research, vol. 41, No. 9, Sep. 1, 1991, pp. 905-909.
“Le raisin”,Journal de Pediatrie et de Puericulture, vol. 11, No. 7, Oct. 1, 1998, p. 444.
Official Communication issued from the European Patent Office on May 14, 2009 for the corresponding European patent application No. 04792636.5.
Office Action issued on Nov. 4, 2009 in corresponding Japanese patent application No. 2005-515111.
Official Communication issued from the Canadian Intellectual Property Office on Apr. 13, 2010 for the corresponding Canadian patent application No. 2,543,676.
Ito Kyoko
Matsumoto Hitoshi
Nakamura Yuko
Yamagishi Megumi
Meiji Seika Kaisha Ltd.
Peselev Elli
Posz Law Group , PLC
LandOfFree
Tyrosinase activity inhibitor and ameliorant for facial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosinase activity inhibitor and ameliorant for facial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosinase activity inhibitor and ameliorant for facial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670156